ArticleFrontiers in cell and developmental biology2021

BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients.

Taohua Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.